Related Experiment Video
Updated: Aug 22, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Reduced Codeine Analgesic Efficacy Associated with Nicardipine in a Patient with Medication-Overuse Headache: A Case
Vincent Arcani1,2, Nicolas Fabresse3, Guillaume Hache1,2
1Aix-Marseille Université, AP-HM, Hôpital de La Timone, Service Pharmacie, Marseille, France.
None:
Codeine is a prodrug opioid whose analgesic efficacy depends on its bioactivation into morphine via cytochrome P450 2D6. Its use in migraine is discouraged because of limited efficacy, tolerance, and the risk of medication-overuse headache. Drug-drug interactions affecting its metabolism may further compromise pain control. We report the case of a 72-year-old man with chronic migraine and daily codeine use. A pharmacist-led medication review identified a potential pharmacokinetic interaction between codeine and extended-release nicardipine. Plasma concentrations of codeine and its metabolites were measured before and after codeine intake under nicardipine treatment and three months after substitution with candesartan. The fold increase in morphine-glucuronide concentration between baseline and peak rose from 1.6 with nicardipine to 3.5 after discontinuation, consistent with restored codeine bioactivation. This case highlights a clinically relevant interaction between nicardipine and codeine leading to reduced opioid efficacy. Beyond tolerance and medication-overuse headache, pharmacokinetic interactions should be systematically considered in patients with refractory pain.
Related Concept Videos
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Analgesia and Pain Management
Drug Toxicity: Dose-Dependent Reactions
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Abuse and Addiction: Pharmacological Phenomena